-
Accelerating and Improving Drug Discovery
Forum for patient advocates explores how researchers are working to develop cancer treatments in a quicker, more efficient manner.
by Thomas Celona
-
Policy Matters
Clinical Trials That Reflect Real-world PatientsA recent article discusses challenges and practical solutions for working toward more diverse and equitable oncology clinical trials.
by Nicholas Warren, PhD
-
Making Clinical Trials Easier
Clinical trials can be hard to find, challenging to get into and difficult to complete. Patient advocates and their supporters want to change that.
by Cameron Walker
-
Get Involved
A Bountiful HarvestFood for the Cure provides fresh produce to people with cancer.
by Thomas Celona
-
Policy Matters
Reigniting the MoonshotPresident Biden proposes increased investment in cancer research and prevention to achieve the goals of the revised Cancer Moonshot.
by Roy S. Herbst, MD, PhD
-
Get Involved
Baked GoodnessSyreeta Harrison sells homemade cupcakes to fund care packages for people with cancer.
by Thomas Celona
-
Building Bridges
AACR Scientist↔Survivor Program celebrates 25 years of sparking conversations between cancer patients and researchers.
by Thomas Celona
-
Get Involved
Making Home a HavenDesigning Dreams performs bedroom makeovers for children with cancer.
by Thomas Celona
-
Policy Matters
Early-career Cancer Researchers Return to WashingtonAACR Early-career Hill Day allows associate members to visit Capitol Hill and advocate for medical research funding.
by Matt Gontarchick
-
Policy Matters
Stemming the E-Cigarette EpidemicAn updated AACR-ASCO joint statement recommends steps for policymakers to lower e-cigarette use among youth and young adults.
by Roy S. Herbst, MD, PhD
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles